UniMed UniHealth Pharmaceuticals

What UniMed UniHealth Pharmaceuticals does

UniMed UniHealth Pharmaceuticals Ltd. is a Bangladeshi pharmaceutical company founded in 2000 and headquartered in Dhaka. The company manufactures and distributes branded generic and generic pharmaceutical products across multiple therapeutic categories, including cardiovascular (Prazopress, Nexcital), respiratory (Nifev, Unifav, PMBL), and dermatology (Nizoder Anti-Dandruff Shampoo). Its manufacturing operates from a single factory in Gazipur, with formulations built using active ingredients and excipients sourced from selected and controlled suppliers, supported by documented quality assurance systems and compliant production facilities. The company also imports and distributes finished pharmaceutical products from international partners such as Lallemand Pharma.

Name

UniMed UniHealth Pharmaceuticals

Legal name

UniMed UniHealth Pharmaceuticals Ltd.

Website

https://unimedunihealth.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

501–1,000 employees

Short description

UniMed UniHealth Pharmaceuticals Ltd. is a Bangladeshi pharmaceutical manufacturer founded in 2000, producing branded generic and generic medicines across cardiovascular, respiratory, neurology, and dermatology therapeutic areas, and distributing them nationwide through a field force and depot network.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

Keywords

• Generic pharmaceuticals
• Branded generic drugs
• Pharmaceutical manufacturing
• Prescription medicines
• Pharmaceutical distribution

Headquarters

HQ city

Dhaka

HQ country

Bangladesh

HQ region

Asia

Offices68 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: The company generates revenue through the manufacture and sale of branded generic and generic pharmaceutical products. Products are distributed through an extensive network of sales depots across Bangladesh. The company also imports and distributes finished goods from international pharmaceutical partners.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

UniMed UniHealth Pharmaceuticals manufactures and distributes branded generic and generic pharmaceutical formulations across multiple therapeutic areas including cardiovascular, respiratory, neurology, dermatology, urology, pain management, and general medicine. The company produces formulations using active ingredients and excipients from selected and controlled sources with traceable quality assurance, and also imports and distributes finished pharmaceutical products from international partners.

Product overview

UniMed UniHealth Pharmaceuticals Ltd is a Bangladeshi pharmaceutical company operating as a single unified pharmaceutical business offering branded generic drugs, generic pharmaceuticals, and imported finished goods. The portfolio includes therapeutic drugs across multiple categories including cardiovascular (Prazopress, Nexcital), respiratory (Nifev, Unifav, PMBL), and dermatological products (Nizoder Anti-Dandruff Shampoo). The company distributes through multiple channels across Bangladesh with regional sales offices and depots.

Differentiator

Problem solved

Functional benefit

Brands

• Unifav (Favipiravir): Anti-viral drug launched in Bangladesh for COVID-19 treatment
• Nifev (Nintedanib)
• Nizoder
• PMBL

Products and services

• Unifav (Favipiravir) Anti-viral pharmaceutical product containing Favipiravir, used for treating viral infections including COVID-19. Launched in Bangladesh during the pandemic period.
• Nifev (Nintedanib) First and only Nintedanib brand available in Bangladesh, used for treating interstitial lung diseases (ILD).
• Prazopress Cardiovascular pharmaceutical product from UniMed UniHealth's portfolio that reached Tk. One crore (10 million Taka) milestone in sales in a single month.
• Nexcital Pharmaceutical product from UniMed UniHealth's portfolio that reached Tk. One crore (10 million Taka) milestone in sales in a single month.
• Nizoder Anti-Dandruff Shampoo Dermatological shampoo product for treating dandruff and seborrheic dermatitis. Received Environment Vanguard Award-2019.
• PMBL Immuno-modulating drug launched under tradename, developed by Lallemand Pharma, used for prophylaxis and treatment of respiratory tract infections and chronic respiratory diseases.
• Generic Pharmaceuticals Portfolio Portfolio of generic pharmaceutical products offered by the company covering multiple therapeutic areas across Bangladesh.
• Branded Pharmaceuticals Portfolio Portfolio of branded pharmaceutical products marketed by the company across cardiovascular, respiratory, neurology, dermatology, urology, pain management, and general medicine.
• Imported Finished Pharmaceuticals Imported finished pharmaceutical products and brands distributed by the company in partnership with international pharmaceutical companies.

Quantifiable outcome

• Reached Tk. 1 crore (10 million Taka) milestone on Prazopress and Nexcital products in a single month.

Named customers1 record

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Seven partnerships are on record, tiered core and minor.

• National Institute of Diseases of the Chest and Hospital (NIDCH)coreStrategic or Co-development Partner · 1 January 2026UniMed UniHealth Pharmaceuticals backs the Specialized Lung Clinic at NIDCH to tackle the rising ILD (Interstitial Lung Disease) burden in Bangladesh. The company provides financial and operational support for the specialized clinic.
• North South University (NSU)coreStrategic or Co-development Partner · 1 January 2025Department of Pharmaceutical Sciences at North South University (NSU) and UniMed UniHealth Pharmaceuticals Ltd. signed a memorandum of understanding to improve the pharmaceutical industry through academic-industry collaboration.
• Lallemand PharmacoreTechnology or Integration · 1 January 2019UniMed UniHealth Pharmaceuticals launched Lallemand Pharma's immuno-modulating drug PMBL under the tradename of the company. This represents a technology/product licensing and distribution partnership for an innovative immuno-modulating therapeutic.
• Bangladesh Basketball FederationminorGTM or Marketing PartnerUniMed UniHealth Pharmaceuticals provided title sponsorship for the UniMed UniHealth Premier Basketball League 2017, organized in partnership with the Bangladesh Basketball Federation. The company also organized the UniMed UniHealth Premier Basketball League 2017 where The Gregarious team won the championship.
• JANSSEN (Pharmaceutical Companies of Johnson & Johnson)minorGTM or Marketing PartnerUniMed UniHealth Pharmaceuticals participated in the Annual Business Meeting of JANSSEN, the pharmaceutical companies of Johnson & Johnson, held in Dhaka.
• Ibrahim Cardiac Hospital & Research Institute (ICHRI)coreStrategic or Co-development PartnerIn association with Ibrahim Cardiac Hospital & Research Institute (ICHRI), UniMed UniHealth Pharmaceuticals organized the Introductory Ceremony of the 1st batch of MD Cardiology students, supporting medical education and cardiac care development in Bangladesh.
• Obstetrical and Gynaecological Society of Bangladesh (OGSB), Comilla BranchminorGTM or Marketing PartnerOGSB Comilla Branch and UniMed UniHealth Pharmaceuticals Ltd. jointly observed the International Fistula Day 2017 to end Obstetric Fistula, demonstrating the company's commitment to women's health CSR initiatives.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• ACI Limited (Pharmaceuticals Division): Diversified Bangladeshi conglomerate with a major pharmaceutical division manufacturing branded generics across therapeutic categories. Comparable manufacturing capabilities, distribution reach, and target prescribers in Bangladesh.
• Square Pharmaceuticals: Largest pharmaceutical manufacturer in Bangladesh, offering branded generic and generic formulations across cardiovascular, respiratory, neurology, and other therapeutic areas through a nationwide distribution network. Directly comparable to UniMed UniHealth in product categories, channels, and customer base.
• Incepta Pharmaceuticals: Leading Bangladeshi pharmaceutical company manufacturing generic and branded generic formulations across diverse therapeutic categories. Directly comparable in product mix, manufacturing scale, and nationwide Bangladesh distribution approach.
• Drug International Limited: Bangladeshi pharmaceutical manufacturer producing a wide range of generic formulations across cardiovascular, respiratory, and other therapeutic areas. Direct competitor in domestic generic market with similar field-sales-driven GTM.
• Eskayef Pharmaceuticals: Bangladeshi pharmaceutical company producing generic and specialty medicines for domestic and export markets. Comparable in therapeutic breadth, manufacturing infrastructure, and physician-channel distribution.
• Beacon Pharmaceuticals: Bangladeshi pharmaceutical manufacturer focused on oncology, specialty, and generic medicines with national distribution. Comparable manufacturer competing in overlapping therapeutic areas including specialty products.
• Beximco Pharmaceuticals: Major Bangladeshi manufacturer and exporter of generic pharmaceuticals across multiple therapeutic areas. Comparable to UniMed UniHealth in branded generic portfolio, domestic distribution, and target customer (physicians and patients in Bangladesh).
• Healthcare Pharmaceuticals: Bangladesh-based pharmaceutical manufacturer with a portfolio spanning multiple therapeutic categories, including branded generics. Comparable mid-sized manufacturer competing for the same prescriber and pharmacy customer base.
• Aristopharma Limited: Bangladesh-based pharmaceutical company manufacturing generic and branded generic products with nationwide distribution. Comparable in scale, therapeutic areas covered, and prescription-driven sales model.
• Renata Limited (Pfizer Bangladesh subsidiary): Bangladeshi pharmaceutical manufacturer producing animal health products, human generics, and specialty medicines with strong domestic distribution. Comparable therapeutic mix and prescriber-targeted go-to-market model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/unimedunihealth

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UniMed UniHealth Pharmaceuticals